Dr. Shen addresses the lack of progress by R&D in developing very necessary new and better biopharma products. Shen suggests that the progress in the development of generic drugs has crippled new research and development of products. The author uses financial data and a number of charts to support his theory. Shen strongly urges scientists to share knowledge for the common good.
[READ THE ARTICLE]